SDGR
Schrödinger, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$20.09
−2.99%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 259.0M | 255.9M | 207.5M | 216.7M | 181.0M |
| Cost of Revenue | 111.7M | 113.3M | 75.5M | 76.0M | 79.9M |
| Gross Profit | 147.3M | 142.6M | 132.1M | 140.7M | 101.0M |
| Operating Expenses | |||||
| R&D Expense | 169.0M | 173.1M | 201.8M | 181.8M | 126.4M |
| SG&A Expense | 131.8M | 136.4M | 139.6M | 136.4M | 121.5M |
| General & Admin Expense | 90.0M | 95.4M | 99.7M | 99.1M | 90.8M |
| Selling & Marketing Expense | 41.7M | 41.0M | 39.9M | 37.2M | 30.6M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 300.8M | 309.5M | 341.4M | 318.1M | 247.8M |
| Cost and Expenses | 412.5M | 422.8M | 416.8M | 394.1M | 327.8M |
| Operating Income (EBIT) | (153.4M) | (166.9M) | (209.3M) | (177.4M) | (146.8M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | 4.0M |
| Interest Expense | — | — | — | — | 3.0K |
| Net Interest Income | — | — | — | — | 3.9M |
| Other Non-Op Income/Expense | 101.5M | 64.6M | 23.6M | 220.4M | (2.3M) |
| Non-Operating Income (excl Interest) | (101.5M) | (64.6M) | (23.6M) | (220.4M) | 2.3M |
| EBT (Pre-Tax Income) | (51.9M) | (102.3M) | (185.7M) | 42.9M | (149.1M) |
| Income Tax Expense | 2.4M | 939.0K | 1.4M | 2.2M | 63.0K |
| Bottom Line | |||||
| Net Income | (54.3M) | (103.3M) | (187.1M) | 40.7M | (149.2M) |
| Earnings from Cont. Ops | (54.3M) | (103.3M) | (187.1M) | 40.7M | (149.2M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (54.3M) | (103.3M) | (187.1M) | 40.7M | (149.2M) |
| Per Share | |||||
| Basic EPS | ($0.74) | ($1.41) | ($2.57) | $0.57 | ($2.10) |
| Diluted EPS | ($0.74) | ($1.41) | ($2.57) | $0.54 | ($2.10) |
| Revenue Per Share | $3.47 | $3.48 | $2.86 | $3.02 | $2.54 |
| Shares | |||||
| Basic Shares Outstanding | 74.7M | 73.4M | 72.7M | 71.8M | 71.2M |
| Diluted Shares Outstanding | 75.8M | 73.4M | 72.7M | 75.0M | 71.2M |
| Profitability Metrics | |||||
| EBITDA | (45.9M) | (96.3M) | (179.6M) | 48.5M | (144.8M) |
| D&A | 6.1M | 6.0M | 6.2M | 5.6M | 4.3M |
| EBIT | (51.9M) | (102.3M) | (185.7M) | 42.9M | (149.1M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026